Skip to main content

Table 1 Active-controlled trials

From: Treatment of established postoperative nausea and vomiting: a quantitative systematic review

Ref Validity score Comparison Surgery Sponsorship
  random blinding dropouts (number of patients in brackets)   
[28] 1/1/0 1) Ondansetron 8 mg iv (50)
2) Droperidol 1.25 mg iv (50)
Not reported  
[29] 2/2/1 1) Ondansetron 0.1 mg/kg iv (16)
2) Droperidol 20 μg/kg iv (13)
Extraabdominal  
[32] 2/2/0 1) Droperidol 1.25 mg iv (27)
2) Metoclopramide 10 mg iv (25)
3) Propofol 10 mg iv (26)
Mixed  
[36] 1/1/0 1) Ondansetron 4 mg iv (380)
2) Metoclopramide 10 mg iv (366)
Not reported Glaxo
[37] 1/1/0 1) Droperidol 20 μg/kg iv (40)
2) Granisetron 40 μg/kg iv (40)
3) Metoclopramide 0.2 mg/kg iv (40)
Laparoscopic
cholecystectomy
 
[38] 1/1/0 1) Droperidol 20 μg/kg iv (40)
2) Granisetron 40 μg/kg iv (40)
3) Metoclopramide 0.2 mg/kg iv (40)
Major
gynecological
 
[39] 1/1/1 1) Alizapride 100 mg iv (24)
2) Droperidol 1 mg iv (25)
3) Ondansetron 8 mg iv (25)
Gynecological Glaxo